InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-06 · accession 0001199719-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-06-09 2025-06-06 SNPS Glaser Shelagh CFO M - OptEx $349.96 +7,310 17.4K +73% +$2.56M
DM 2025-06-09 2025-06-06 SNPS Glaser Shelagh CFO S - Sale+OE $485.72 -7,310 15.3K -32% -$3.55M
DM 2025-06-09 2025-06-06 SNPS Glaser Shelagh CFO M - OptEx $0.00 -7,310 15.7K -32% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-06 M A 5,224 $348.17 20,515 D — —
2 Common Common Stock 2025-06-06 S D 2,086 $485.72 15,291 D — — (F1) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $483.38 to $487.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
3 Common Common Stock 2025-06-06 M A 2,086 $354.45 17,377 D — —
4 Common Common Stock 2025-06-06 S D 5,224 $485.72 15,291 D — — (F1) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $483.38 to $487.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
5 Derivative Non-Qualified Stock Option (right to buy) 2025-06-06 M D 2,086 $0.00 7,452 D $354.45 · 2024-02-17 to 2030-02-17 2,086 Common Stock (F3) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
6 Derivative Non-Qualified Stock Option (right to buy) 2025-06-06 M D 5,224 $0.00 15,673 D $348.17 · 2023-12-02 to 2029-12-02 5,224 Common Stock (F3) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.